We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

116 hedge funds and large institutions have $615M invested in AnaptysBio in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 11

2.99% more ownership

Funds ownership: 111.13% → 114.12% (+3%)

3% more funds holding

Funds holding: 113 → 116 (+3)

9% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 35

2% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $1.18M

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less capital invested

Capital invested by funds: $675M → $615M (-$60.4M)

Holders
116
Holders Change
+3
Holders Change %
+2.65%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
38
Reduced
35
Closed
11
Calls
$1.2M
Puts
$1.18M
Net Calls
+$29K
Net Calls Change
-$106K

Top Buyers

1
WP
Woodline Partners
California
+$11.7M
2
FLAM
First Light Asset Management
Minnesota
+$6.53M
3
B
Braidwell
Connecticut
+$3.68M
4
Millennium Management
Millennium Management
New York
+$2.78M
5
GPP
Great Point Partners
Connecticut
+$1.82M

Top Sellers

1
Federated Hermes
Federated Hermes
Pennsylvania
-$26.4M
2
RSCM
Rock Springs Capital Management
Maryland
-$4.76M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$4.49M
4
JP Morgan Chase
JP Morgan Chase
New York
-$3.78M
5
Northern Trust
Northern Trust
Illinois
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$4.12M -$2.64M -129,993 -39%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$4.04M +$795K +39,214 +25%
Citadel Advisors
28
Citadel Advisors
Florida
$3.13M +$1.5M +73,910 +92%
Two Sigma Investments
29
Two Sigma Investments
New York
$2.97M +$1.52M +75,193 +106%
Charles Schwab
30
Charles Schwab
California
$2.84M -$198K -9,774 -7%
Goldman Sachs
31
Goldman Sachs
New York
$2.69M -$1.09M -53,564 -29%
Two Sigma Advisers
32
Two Sigma Advisers
New York
$2.56M +$1.16M +57,100 +83%
UOC
33
UBS O'Connor
Illinois
$2.53M +$182K +8,984 +8%
Bank of America
34
Bank of America
North Carolina
$2.45M +$113K +5,554 +5%
Macquarie Group
35
Macquarie Group
Australia
$1.91M – – –
Rafferty Asset Management
36
Rafferty Asset Management
New York
$1.88M +$311K +15,316 +20%
ECM
37
ExodusPoint Capital Management
New York
$1.8M -$922K -45,457 -34%
Ameriprise
38
Ameriprise
Minnesota
$1.79M +$21K +1,035 +1%
N
39
Nuveen
North Carolina
$1.47M -$77.2K -3,808 -5%
Morgan Stanley
40
Morgan Stanley
New York
$1.46M -$548K -27,012 -27%
Fisher Asset Management
41
Fisher Asset Management
Washington
$1.44M – – –
Bank of New York Mellon
42
Bank of New York Mellon
New York
$1.41M -$134K -6,623 -9%
Renaissance Technologies
43
Renaissance Technologies
New York
$1.18M -$276K -13,600 -19%
SG Americas Securities
44
SG Americas Securities
New York
$1.16M -$23.6K -1,164 -2%
Hudson Bay Capital Management
45
Hudson Bay Capital Management
Connecticut
$1.02M +$1.01M +50,000 New
Barclays
46
Barclays
United Kingdom
$990K +$290K +14,308 +42%
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
$884K – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$866K +$116K +5,700 +15%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$833K -$367K -18,112 -31%
HS
50
HighVista Strategies
Massachusetts
$766K +$252K +12,432 +49%
1
2
3 4 5

ANAB Hedge Fund Activity: Q2 2023 in Review

116 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q2 2023, worth a combined $615M — down 8.9% from $675M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ANAB positions and 11 closed out — a net gain of 3 holders — while 38 added to existing stakes and 35 trimmed.

The largest buyer was Woodline Partners, adding an estimated $11.7M. The largest seller was Federated Hermes, cutting an estimated $26.4M.

  • 116 institutional investors held AnaptysBio (ANAB) as of Q2 2023, up from 113 in Q1 2023.
  • Funds reported $615M of AnaptysBio stock for Q2 2023, down 8.9% quarter-over-quarter.
  • 14 funds opened new AnaptysBio positions in Q2 2023 and 11 closed out, a net change of +3 holders.
  • The largest AnaptysBio buyer in Q2 2023 was Woodline Partners, an estimated $11.7M added.
  • The largest AnaptysBio seller in Q2 2023 was Federated Hermes, an estimated $26.4M sold.

Based on aggregated 13F filings for Q2 2023.